Aktuella utlysningar, vecka 38, 2021
Grants Office tipsar om aktuella utlysningar.
Svenska och nordiska utlysningar
Research grants - Swedish Rheumatism Association
Support research aimed at reducing the morbidity of rheumatic diseases, increasing the quality of life of people with rheumatic disease and preventing rheumatic disease. Grants may last for up to two years.
Closing date: 30 September 2021
Research grants for rehabilitation - Swedish Rheumatism Association
Support research in the field of rehabilitation in rheumatic inflammatory disease.
Closing date: 30 September 2021
Pulmonary medical research grants - Swedish Respiratory Society
Support projects that are of high quality and good clinical potential in clinical pulmonary medicine and aim to stimulate the implementation of urgent research projects in Sweden. The total budget is SEK 500,000 and grants are awarded to a maximum of two applicants.
Closing date: 30 September 2021
Obstetrics and gynaecology grant - Nordic Federation of Societies of Obstetrics and Gynecology
Supports the development of professional skills, research, and clinical and scientific collaboration in the fields of obstetrics and gynaecology within the Nordic countries. Grants may cover course fees, travelling expenses, accommodation, meeting expenses, expenses related to work in developing countries and speakers fees.
Closing date: 1 October 2021
Hilda och Alfred Erikssons pris 2022
Kungl. Vetenskapsakademien inbjuder till nominering för Hilda och Alfred Erikssons pris.
Signerat skriftligt motiverat förslag önskas senast den 1 oktober 2021.
Patient-centered research - Stiftelsen för Njursjuka
Supports research on patients with chronic advanced renal failure or who have had a kidney transplant. The total budget is SEK 400,000.
Closing date: 1 October 2021
Project grants - Parkinson Research Foundation
Support research on treatments to slow down or cure Parkinson's disease and other neurodegenerative diseases. The total budget is up to SEK 1 million.
Closing date: 1 October 2021
Forskningsanslag – Spädbarnsfonden
Spädbarnsfonden utlyser en gång per år medel för stöd till forskning med syfte att förebygga att barn dör före födelsen eller under spädbarnsperioden. Forskningen kan även handla om att förbättra bemötandet av drabbade föräldrar och närstående. Anslag kan sökas för biomedicinsk forskning, inom fostermedicin och nyföddhetsvård, och för omvårdnads- och vårdvetenskaplig samt psykosocial forskning. Medel kan sökas av disputerade forskare samt registrerade doktorander.
Closing date: 31 October 2021
Swelife and Medtech4Health: Collaborative projects for better health - Vinnova
With this call for proposals, Swelife and Medtech4Health want to help Sweden remain a world leader in life science. The goal is to promote renewal and innovation for a more value-creating healthcare and increase growth in the life science sector in Sweden. The call is aimed at actors in collaboration in the sectors of healthcare, companies, academia, research institutes and actors in the idea-driven sector. Grants are worth between SEK 500,000 and SEK 3 million each for up to two years.
Closing date: 24 November 2021
ERC 2022 Starting Grant
ERC Starting Grants support excellent researchers who are starting their own independent research team or programme. Applications may be made in any field of research with an emphasis on the frontiers of science, scholarship and engineering.
PIs should have been awarded their first PhD between two and seven years prior to January 1st 2022, and must have produced at least one important publication as main author or without the participation of their PhD supervisor. Host institutions must be established in EU members states or associated countries.
The total call budget is €749 million, with individual grants worth up to €1.5m each over five years (an additional €1m may be requested for eligible start-up costs of moving to the EU or an associated country, the purchase of major equipment, access to large facilities and major experimental and field work costs).
Closing date: 13th January 2022
ERC 2022 Consolidator Grant
ERC consolidator grants enable excellent researchers to consolidate their independence by establishing or strengthening a research team. Applications may be made in any field of research with an emphasis on the frontiers of science, scholarship and engineering.
PIs should have been awarded their PhD between seven and 12 years prior to January 1st 2022, and must show evidence of research independent, for example by having produced several important publications as main author or without participation of their PhD supervisor. Host institutions must be established in EU members states or associated countries
The total call budget is €776 million, with individual grants worth up to €2 million over five years (an additional €1m may be requested for eligible start-up costs of moving to the EU or an associated country, purchase of major equipment, access to large facilities and other major experimental and field work costs).
Closing date: 17th March 2022
EFSD and EUDF digitalisation in diabetes care research grant - European Association for the Study of Diabetes
The European Foundation for the Study of Diabetes and the European Diabetes Forum invites applications for their digitalisation in diabetes care research grant. This supports the translation of research into policy actions towards better diabetes care at European and national level. The aim is to stimulate and accelerate European research aimed at optimising the use of technology, digital health and innovative treatments to support self-care by people with diabetes, to prevent complications and support quality of life. Studies forming part of a larger project are accepted.
Single or groups of non-profit institutions from Europe and associated countries may apply. The PI and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work based in Europe or an associated country. Grants are worth up to €40,000 for at least one year.
Closing date: 15th November 2021
COST action call - European Cooperation in Science and Technology
European Cooperation in Science and Technology (COST) invites proposals for its action call. This supports networking activities such as meetings, short-term scientific missions, training schools and dissemination activities in the areas of science and technology. The aim is to foster the scientific, technological, economic, cultural or societal knowledge advancement and development of Europe.
Projects must include a network of proposers from at least seven COST member countries or cooperating states. Half of the countries in the project group must be inclusiveness target countries, namely Albania, Bosnia-Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Moldova, Montenegro, Poland, Portugal, Romania, Slovenia, Slovakia, the Republic of North Macedonia, the Republic of Serbia and Turkey. Applicants may be researchers and innovators from different fields and horizons such as universities, research centres and companies, in particular small and medium-sized enterprises, as well as other relevant actors. Grants are worth approximately €129,000 per year for four years.
Closing date 29 October 2021
Federal Funding agencies
Biobehavioural basis of chronic pain (R01, R21 clinical trial optional), NIH
The purpose of the Funding Opportunity Announcement is to encourage grant applications from the scientific community on the biobehavioral basis of chronic pain. The focus encompasses the individual phenotype, genotype, and other omic-type assessments and the associated sensory and emotional components that underpin the individual’s chronic pain experience. Research relating biology and behavior is needed to better define the individual-specific burden of chronic pain and to better understand the mechanisms underlying differences in pain experiences among individuals afflicted with the same chronic illness.
Closing date: Standard dates apply. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PA-18-944 (R01), PA-18-943 (R21)
Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01, R21 Clinical Trial Optional), NIH
The purpose of this Funding Opportunity Announcement (FOA) is to support studies to better comprehend the mechanisms contributing to the CNS co-morbidities in people living with HIV on Anti-Retroviral therapy by deciphering the Immune-Central Nervous System (CNS) interactions. Applications testing a fully conceptualized and hypothesis-based premise founded on adequate preliminary data are appropriate for this FOA. Applicants pursuing exploratory and high-risk research projects should be submitted to the companion R21 announcement, RFA-MH-21-251. Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.
Closing date: December 07, 2021. Letter of Intent Due Date: November 07, 2021. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-MH-21-250 (R01), RFA-MH-21-251 (R21)
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed), NIH
Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including structural birth defects (SBDs), intellectual developmental disabilities (IDDs) and inborn errors of metabolism (IEMs). Large quantities of genomic data collected from pediatric birth defects cohorts are available to the research community through several databases such as the Database of Genotypes and Phenotypes (dbGaP), the Gabriella Miller Kids First Data Resource Portal, the European Genome-Phenome Archive and Clinical Genome Resource (ClinGen). The purpose of this initiative is to promote the screening, functional validation and characterization of birth defects-associated genetic variants identified through public facing databases and individual efforts using in-silico tools, appropriate animal models, in vitro systems or multi-pronged approaches. This initiative addresses a challenging gap between identifying sequence variations of potential interest and recognizing which of those variations have functional effects on the phenotype of interest.
Closing date: February 05, 2022; June 05, 2022, February 05, 2023, June 05, 2023, February 05, 2024, June 05, 2024, February 05, 2025. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-21-229
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed), NIH
The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory research focused on developing innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the infectious or immune-mediated disease research continuum aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation.
As a part of the trans-NIAID Data Science program, this R21 FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods, including artificial intelligence and machine learning approaches, that can considerably improve acquisition, management, analysis, visualization, and dissemination of relevant data and/or knowledge.
Closing date: February 17, 2022; July 1, 2022; February 17, 2033; July 6, 2023. Letter of Intent Due Date: 30 days prior to the application due date. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-AI-21-035
Fellowships 2021 Call, The IBSA Foundation
With the aim of promoting and allowing young and talented researchers to do great science, IBSA Foundation offers 6 fellowships of € 30,000 in the following research fields: dermatology, endocrinology, fertility and urology, orthopaedics and rheumatology, pain medicine and for the 2021 special edition “regenerative medicine”
Applicants of any nationality must be under 40 years old on the deadline for the submission of proposals. They must have a degree in medicine, biology, pharmacy, biotechnology or bioengineering. Open to PhD students, PhD, Post-Doc and residents. Permanent positions such as Professors cannot apply.
For the entire duration of the grant, applicants must be active in the Host Institution, i.e. a research organization (such as universities, hospitals or other research centres), irrespective of its legal status (organized under public or private law), whose primary goal is to independently conduct non-economic biomedical research and to disseminate its results.
Closing date: December 31, 2021